Altitude & Mountaineering Performance Protocol
Altitude & Mountaineering Performance Protocol framework focused on consistent execution, practical monitoring, and safer progression.
A protocol for mountaineers, altitude athletes, and competitive cyclists targeting improved hypoxic adaptation, pulmonary vasodilation to prevent HAPE, enhanced oxygen utilization efficiency, and accelerated recovery from altitude-induced tissue stress.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Altitude & Mountaineering Performance Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
AICAR 2 weeks pre-expedition + throughout. VIP during ascent phase only. Others continuous for expedition duration.
Target Audience
Mountaineers, high-altitude trekkers, competitive cyclists at altitude, and expeditionary athletes above 3000m
| Compound | Dose | Frequency |
|---|---|---|
| AICAR AICAR: activates AMPK and HIF-1α; accelerates mitochondrial biogenesis and oxidative adaptation equivalent to weeks of altitude exposure | 50–100 mg | Daily SC, starting 2 weeks pre-expedition |
| VIP VIP: pulmonary vasodilator; reduces hypoxic pulmonary vasoconstriction to decrease HAPE risk; also anti-inflammatory in pulmonary endothelium | 50–100 mcg | Daily SC during ascent phase |
| MOTS-c MOTS-c: improves mitochondrial electron transport chain efficiency; increases ATP per O₂ molecule critical at reduced partial pressures | 5–10 mg | Daily SC |
| BPC-157 BPC-157: protects pulmonary endothelium from altitude-induced inflammatory injury; reduces gut permeability stress from high-altitude diet disruption | 250 mcg | Twice daily SC |
| Sermorelin Sermorelin: GHRH analogue; maintains GH pulsatility during extended high-altitude metabolic stress; supports lean mass against altitude-induced catabolism | 200–300 mcg | Daily SC |
| Ipamorelin Ipamorelin: selective GH secretagogue paired with Sermorelin; preserves muscle mass and accelerates recovery between summit attempts | 200 mcg | Daily SC |
Free Peptide Guide
Altitude & Mountaineering Performance Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned AICAR timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Altitude & Mountaineering Performance Protocol run before reassessment?
A common window is AICAR 2 weeks pre-expedition + throughout. VIP during ascent phase only. Others continuous for expedition duration., with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with AICAR + VIP execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
Altitude above 3000m triggers hypoxia-inducible factor (HIF-1α) cascades that require days to weeks for full acclimatization, during which performance is severely impaired and HAPE risk is elevated. AICAR activates AMPK and stimulates HIF-1α expression, accelerating mitochondrial biogenesis and oxidative enzyme upregulation that normally requires weeks of hypoxic exposure. VIP (vasoactive intestinal peptide) is a potent pulmonary vasodilator that reduces hypoxic pulmonary vasoconstriction, the core mechanism of HAPE. MOTS-c improves mitochondrial electron transport chain efficiency, allowing greater ATP production per oxygen molecule at altitude. BPC-157 protects pulmonary endothelium from altitude-induced inflammatory signaling. Sermorelin with Ipamorelin maintain GH output during the metabolic stress of extended high-altitude expeditions.
Clinical Research
No clinical references were provided for this stack yet.
More General Wellness Stacks
COPD & Pulmonary Rehabilitation Protocol
An adjunctive protocol for individuals with COPD and other chronic lung diseases targeting the airway inflammation, pulmonary fibrosis, mucociliary dysfunction, and systemic muscle wasting that drive progressive respiratory decline.
Chronic Kidney Disease (CKD) Support Protocol
A nephroprotective protocol for patients with CKD stages 2–4, addressing progressive renal inflammation, anemia, muscle wasting (sarcopenia), peripheral neuropathy, and immune suppression through carefully selected peptides with renal safety profiles.
Chronic Kidney Disease Progression Slowing Protocol
An adjunctive protocol for individuals with CKD stages 2–4 targeting the mitochondrial dysfunction, inflammatory nephropathy, and oxidative damage that drive progressive kidney function decline.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Altitude & Mountaineering Performance Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.